31st Jul 2009 07:00
31 July 2009
Ultrasis plc ("Ultrasis" or "the Company")
Allotment of performance shares and Block Listing Application
Ultrasis has today allotted 2,950,000 new ordinary shares in relation to the acquisition of Get Fit Technologies Ltd on 18 December 2008. These shares (the "bonus shares") were issued for achievement of performance criteria and fulfilling employment obligations set at the time of acquisition. Accordingly, application has been made for admission of 2,950,000 ordinary shares to trading on AIM and admission is expected to be effective on 4 August 2009.
The Company has also today applied for a block listing of 111,500,000 ordinary shares to be issued when options are exercised under the Unapproved and EMI Share Option Scheme. The rules of the Unapproved Share Option Scheme have recently been amended to allow for 'net settlement' which enables a fewer number of shares to be issued in fulfilment of the existing share options thereby reducing the dilutive effects.
Under the block listing, the shares issued following exercise of options will be admitted to AIM as issued and Ultrasis will confirm the number of shares so admitted every six months.
For further information please contact:
Ultrasis plc
Nigel Brabbins, Chief Executive
+44 (0) 20 7566 3900
Geoff Nash,
FinnCap
Nominated Advisor and Joint Broker
+44 (0) 207600 1658
John Webb,
Marshall Securities
Joint Broker
+44 (0) 207 490 3788
Media Enquiries
JBP
Karen White/Rebecca Hosgood
+44 (0) 117 9073400
[email protected] ; [email protected]
or visit:
www.ultrasis.com
www.getfitwellness.com
Notes to Editors
Ultrasis plc is a healthcare company with core expertise in health, psychology, software development and programme management. The Company delivers computerised healthcare products to the NHS, the corporate sector and other healthcare providers in the UK and internationally.
Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy and interactive multimedia, and is the world leader in this field. The products help people tackle stress, anxiety and depression, and a full spectrum of related conditions.
Related Shares:
Ultrasis Plc